Elon Musk accuses App Store of favoring OpenAI
Factors going into App Store rankings include user engagement, reviews, and the number of downloads.
SAN FRANCISCO - Mr Elon Musk has taken his feud against OpenAI to the App Store, accusing Apple of favouring ChatGPT in the digital shop and
vowing legal action.
'Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in the App Store, which is an unequivocal antitrust violation,' Mr Musk said in a post on his social network X on Monday, without providing evidence to back his claim.
'xAI will take immediate legal action,' he added, referencing his own artificial intelligence company.
X users responded by pointing out that DeepSeek AI out of China hit the top spot in the App Store early in 2025, and Perplexity AI recently ranked number one in the App Store in India.
DeepSeek and Perplexity compete with OpenAI and Musk's startup xAI.
Both OpenAI and xAI released new versions of their AI assistants, ChatGPT and Grok, in the past week.
App Store rankings on Aug 12 listed ChatGPT as the top free iPhone app with Grok in fifth place.
Apple did not immediately respond to a request for comment.
Factors going into App Store rankings include user engagement, reviews, and the number of downloads.
OpenAI and Apple in June 2024 announced an alliance to enhance iPhones and other devices with ChatGPT features.
ChatGPT-5 rolled out free to the nearly 700 million people who use it weekly, OpenAI said in a briefing with journalists last week.
Tech industry rivals Amazon, Google, Meta, Microsoft and xAI have been pouring billions of dollars into artificial intelligence since the blockbuster launch of the first version of ChatGPT in late 2022.
Chinese startup
DeepSeek shook up the AI sector early in 2025 with a model that delivers high performance using less costly chips.
OpenAI in April filed counterclaims against multi-billionaire Musk, accusing its former co-founder of waging a 'relentless campaign' to damage the organisation after it achieved success without him.
In legal documents filed at the time in northern California federal court, OpenAI alleged Mr Musk became hostile toward the company after abandoning it years before its breakthrough achievements with ChatGPT.
The lawsuit was another round in a bitter feud between the generative AI (genAI) start-up and the world's richest man, who sued OpenAI in 2024, accusing the company of betraying its founding mission.
In its countersuit, the company alleged Mr Musk 'made it his project to take down OpenAI, and to build a direct competitor that would seize the technological lead – not for humanity but for Elon Musk'.
Mr Musk founded his own genAI startup, xAI, in 2023 to compete with OpenAI and the other major AI players. AFP

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNA
3 hours ago
- CNA
Musk's X back up after brief outage, Downdetector shows
Elon Musk's X was back up for thousands of users in the U.S. after a short outage on Thursday, according to tracking website Th outage eased to nearly 600 incidents of people reporting issues with the social media platform as of 11:20 a.m. ET, compared to a peak of more than 18,000 user reports, according to Downdetector. Downdetector tracks outages by collating status reports from a number of sources. Since the numbers are based on user-submitted reports, the actual number of affected users may vary.

Straits Times
4 hours ago
- Straits Times
Apple to bring blood oxygen feature to some US watches with software update
Sign up now: Get ST's newsletters delivered to your inbox The software update will allow Apple Watch users in the US to view their blood oxygen levels on a paired iPhone. SAN FRANCISCO – Apple will bring a blood oxygen measurement feature to some of its watch models via a software update after receiving approval from the US government amid a protracted legal dispute over the technology, it said on Aug 14. The move will allow users of Apple Watch Series 9, Series 10 and Apple Watch Ultra 2 in the United States to view their blood oxygen levels on a paired iPhone. It comes after years of legal wrangling with Irvine, California-based Masimo, which has accused Apple of hiring its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo won a ruling at the US International Trade Commission (ITC) to block imports of watches with the feature, which prompted Apple to remove the feature and set off a lengthy appeals process. The watch models affected did not have the blood oxygen feature when shipped, but Apple said US Customs had approved the software update. With the update, a user can start a session in the blood oxygen app on Apple Watch, and the Apple Watch sensors will collect data that will be used by the iPhone to calculate and display the levels, Apple said. Apple first introduced pulse oximetry in its Series 6 Apple Watches in 2020. Masimo released its blood oxygen tracking W1 watch in 2022. Top stories Swipe. Select. Stay informed. Singapore Over 100 people being investigated for vape offences, say MOH and HSA Singapore Bukit Merah fire: Residents relocated as town council carries out restoration works Singapore askST: What to do in the event of a fire at home Singapore Jalan Bukit Merah fire: PMD battery could have started fatal blaze, says SCDF Singapore askST: What are the fire safety rules for PMDs? Asia AirAsia flight from KL to Incheon lands at wrong airport in South Korea Opinion Could telco consolidation spell the end of attractive mobile plans? Singapore From quiet introvert to self-confident student: How this vulnerable, shy teen gets help to develop and discover her strength Masimo convinced the ITC to block imports of Apple's Series 9 and Ultra 2 smartwatches in 2023, based on the commission's determination that Apple's technology for reading blood oxygen levels infringed upon Masimo's patents. Apple temporarily resumed sales of the watches the next day after persuading the Federal Circuit to pause the ban. The Federal Circuit reinstated the ban the next month, leading Apple to remove pulse oximetry capabilities from its watches in the US. Masimo did not immediately respond to a request for comment. REUTERS


CNA
5 hours ago
- CNA
Apple to bring blood oxygen feature to some US watches with software update
SAN FRANCISCO :Apple will bring a blood oxygen measurement feature to some of its watch models via a software update after receiving approval from the U.S. government amid a protracted legal dispute over the technology, it said on Thursday. The move will allow users of Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 in the United States to view their blood oxygen levels on a paired iPhone. It comes after years of legal wrangling with Irvine, California-based Masimo, which has accused Apple of hiring its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo won a ruling at the U.S. International Trade Commission to block imports of watches with the feature, which prompted Apple to remove the feature and set off a lengthy appeals process. The watch models affected Thursday did not have the blood oxygen feature when shipped, but Apple said U.S. Customs had approved the software update. With the update, a user can start a session in the blood oxygen app on Apple Watch, and the Apple Watch sensors will collect data that will be used by the iPhone to calculate and display the levels, Apple said. Apple first introduced pulse oximetry in its Series 6 Apple Watches in 2020. Masimo released its blood oxygen tracking W1 watch in 2022. Masimo convinced the ITC to block imports of Apple's Series 9 and Ultra 2 smartwatches in 2023, based on the commission's determination that Apple's technology for reading blood oxygen levels infringed upon Masimo's patents. Apple temporarily resumed sales of the watches the next day after persuading the Federal Circuit to pause the ban. The Federal Circuit reinstated the ban the next month, leading Apple to remove pulse oximetry capabilities from its watches in the United States.